Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »
Pharmaceutical companies competing to develop coronavirus vaccines are already working behind the scenes to build the supply chains necessary to deliver their drugs to billions of people as quickly as possible. To meet global demand once a vaccine is approved, a complicated and high-risk supply chain would be put in …
Read More »
Text size Albert Bourla, CEO of the pharmaceutical company Pfizer Drew Angerer / Getty Images Albert Bourla, Pfizer‘s CEO, he has no patience with the argument that pharmaceutical companies should not make a profit from the drugs and vaccines they introduce to fight Covid-19. “I think it is very bad,” …
Read More »
Pfizer Inc. PFE, -0.31% and BioNTech SE BNTX, + 2.80% He said Monday night that they have started a late-stage clinical trial for one of their COVID-19 vaccine candidates, which involves 30,000 people worldwide. The start of the trial “is a great step forward in our progress towards the provision …
Read More »